ANAPTYSBIO, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $19.8M | $416.6M | $250.5M |
| FY2021 | $286.6M | $643.1M | $495.7M |
| FY2022 | $348.3M | $610.4M | $71.3M |
| FY2023 | $364.3M | $452.4M | $36.0M |
| FY2024 | $413.0M | $483.8M | $123.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $19.8M | $416.6M | $250.5M |
| FY2021 | $286.6M | $643.1M | $495.7M |
| FY2022 | $348.3M | $610.4M | $71.3M |
| FY2023 | $364.3M | $452.4M | $36.0M |
| FY2024 | $413.0M | $483.8M | $123.1M |